Immunovative Therapies Company
Immunovative Therapies is an Israeli company specializing in using living immune cells for the treatment of cancer and infectious diseases.
Technology:
Biologics (Ab), CAR-T therapy, Cell therapy, Cell-based gene therapy
Industry:
Geroscience, Private
Headquarters:
Jerusalem, Yerushalayim, Israel
Founded Date:
2004-01-01
Employees Number:
51-100
Investors Number:
4
Total Funding:
16500000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2012-01-20
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership